Internal Medicine, Pulmonary Disease · Manati, PR
NPI
1801898309
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
E36 Calle Hernandez Carrion, Urb Atenas
Manati, PR, 00674
Phone (787) 884-4478
Medicare paid, 2024
$23K
364 services
Medicare patients, 2024
99
Average age 73
Drug cost, 2024
$2.0M
9,700 prescriptions
Company payments, 2025
$105
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samuel A Amill-Acosta was code 99232 (hospital e&m - subsequent), 128 times for 21 patients. In total Samuel A Amill-Acosta billed 364 services in 17 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 128 | 21 | $50.65 | $6,483 |
| 99213 Office E&M - Established | Office | 81 | 66 | $47.79 | $3,871 |
| 94060 Pulmonary Function Testing | Office | 29 | 29 | $30.66 | $889 |
| 94729 Pulmonary Function Testing | Office | 29 | 29 | $31.81 | $922 |
| 94726 Pulmonary Function Testing | Office | 28 | 28 | $44.03 | $1,233 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $134.07 | $1,475 |
By year: 2022 $18K for 259 services; 2023 $23K for 315 services; 2024 $23K for 364 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samuel A Amill-Acosta prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,547 prescriptions and refills. In total Samuel A Amill-Acosta wrote 9,700 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,547 | 1,571 | 421 | $61K |
| Fluticasone Propionate Generic | 1,163 | 1,276 | 324 | $20K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 1,102 | 1,138 | 321 | $296K |
| Montelukast Sodium Generic | 990 | 1,157 | 267 | $8,403 |
| Proair Respiclick Albuterol Sulfate | 661 | 669 | 213 | $47K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 602 | 616 | 183 | $71K |
| Spiriva Respimat Tiotropium Bromide | 487 | 491 | 137 | $261K |
| Azelastine Hcl Generic | 409 | 592 | 154 | $8,691 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 301 | 306 | 97 | $56K |
| Symbicort Budesonide/Formoterol Fumarate | 250 | 253 | 101 | $60K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 235 | 239 | 52 | $159K |
| Methylprednisolone Generic | 231 | 231 | 213 | $6,164 |
| Breo Ellipta Fluticasone/Vilanterol | 179 | 184 | 43 | $76K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 172 | 176 | 43 | $86K |
| Azelastine-Fluticasone Azelastine/Fluticasone | 142 | 157 | 49 | $14K |
Brand drugs: 5,129 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samuel A Amill-Acosta $105 ($105 in general payments such as food, travel and fees) from 3 companies. The largest payer was Genzyme Corporation with $47.62.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.